| Fatal outcome of posterior “reversible” encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen N Dedić Plavetić, Z Rakušić, D Ozretić, L Simetić, AM Krpan, V Bišof World journal of surgical oncology 12, 1-4, 2014 | 29 | 2014 |
| SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA–KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak … N Dedić Plavetić, T Silovski, A Tečić Vuger, M Pavlović, L Vazdar, ... Liječnički vjesnik 140 (3-4), 0-0, 2018 | 9 | 2018 |
| Relative change in S100 as a biomarker of survival in patients with metastatic melanoma treated with pembrolizumab L Simetić, K Blažičević, K MEĐUGORAC, M GOLČIĆ, D Herceg Anticancer Research 40 (4), 2157-2163, 2020 | 5 | 2020 |
| Could fecal microbial transplantation offer a new potential in the treatment of metastatic pancreatic ductal adenocarcinoma? M Golčić, L Simetić, T Majnarić, G Golčić, D Herceg Medical hypotheses 161, 110801, 2022 | 4 | 2022 |
| Analysis of the gut microbiome and dietary habits in metastatic melanoma patients with a complete and sustained response to immunotherapy M Golčić, L Simetić, D Herceg, K Blažičević, G Kenđel Jovanović, I Dražić, ... Cancers 15 (11), 3052, 2023 | 3 | 2023 |
| Severe demyelinating polyneuropathy and cranial neuropathy during avelumab treatment of metastatic Merkel cell carcinoma H Bilić, B Sitaš, M Hančević, M Habek, L Simetić, E Bilić Clinical neuropharmacology 44 (5), 193-195, 2021 | 3 | 2021 |
| Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe: An initiative of the Central European Cooperative Oncology Group (CECOG) C Thallinger, P Berzinec, E Bicakcic, A Dan, G Fabian, LN Gales, ... Wiener klinische Wochenschrift 134 (19-20), 697-704, 2022 | 2 | 2022 |
| Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin L Simetić, K Blažičević, T Ladenhauser, M Golčić, T Majnarić, D Herceg Anti-cancer drugs 32 (10), 1058-1066, 2021 | 2 | 2021 |
| Rituximab as a treatment option in a patient with rheumatoid arthritis and a history of malignancy—intracranial chondrosarcoma/osteochondroma—case based review M Barešić, I Ježić, L Simetić, D Herceg, B Anić Rheumatology international 41 (2), 463-468, 2021 | 2 | 2021 |
| Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients A Pokupec Bilić, I Bilić, S Radić Brkanac, L Simetić, K Blažičević, ... Clinical and Translational Oncology, 1-11, 2024 | | 2024 |
| Successful clinical approach to the metastatic uterine leiomyosarcoma to the epicardium—a case report K Krzelj, A Lekic, VR Luksic, D Milicic, I Ilic, L Simetic, ZS Dzepina, ... BMC Cardiovascular Disorders 24 (1), 49, 2024 | | 2024 |
| THE DIFFERENCE IN GUT MICROBIOME COMPOSITION OF MELANOMA PATIENTS REGARDING THEIR DIETARY FIBER INTAKE GK Jovanović, M Golčić, L Simetić, D Herceg, K Blažević, I Dražić, ... MDPI, 2023 | | 2023 |
| Personalized Dietary Intervention Based on Mediterranean Diet as a Complementary Strategy to Modify Gut Microbiome, Quality of Life and Outcomes in Patients with Metastatic … N Skočibušić, A Belančić, GK Jovanović, M Golčić, D Herceg, L Simetić, ... Biology and Life Sciences Forum 29 (1), 23, 2023 | | 2023 |
| Personalized dietary intervention as a complementary strategy to modify gut microbiome signature and improve immunotherapy outcomes in cancer patients N Skočibušić, A Belančić, GK Jovanović, M Golčić, D Herceg, L Simetić, ... MDPI, 2023 | | 2023 |
| 1172P Analysis of the microbiome of metastatic melanoma patients with complete response to immunotherapy M Golcic, L Simetic, D Herceg, K Blazicevic, G Kenđel-Jovanović, I Dražić, ... Annals of Oncology 34, S696, 2023 | | 2023 |
| Merkel Cell Carcinoma of Unknown Primary Origin H Francetić, L Simetić, Č Tomasović Lončarić, D Štulhofer Buzina, ... Acta Dermatovenerologica Croatica 31 (3), 153-155, 2023 | | 2023 |
| META GENOMSKA ANALIZA CRIJEVNOG MIKROBIOMA U PACIJENATA S KOMPLET NIM I ODRŽA NIM ODGOVOROM NA IMUNOTERAPIJU INHIBITORIMA KONTROLNIH TOČAKA. M GOLČIĆ, L Simetić, D Herceg, K Blažičević, G Kenđel-Jovanović, ... Lijecnicki Vjesnik 145, 2023 | | 2023 |
| SARKOMI S CIC-PREUREDBOM GENA: PRIKAZ SERIJE SLUČAJEVA. J VRBANEC, A Kelečić, D Herceg, K Blažičević, A Breški, S Dotlić, ... Lijecnicki Vjesnik 145, 2023 | | 2023 |
| Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma T Batinac, N Hlača, L Simetić, F Valković, S Peternel, L Prpić-Massari Acta dermato-venereologica 102, adv00650-adv00650, 2022 | | 2022 |
| MERKEL CELL CARCINOMA WITHOUT A PRIMARY CUTANEOUS LESION CASE REPORT H Francetić, M Prtajin, L Simetić, Č Tomasović Lončarić, ... 7 Kongres hrvatskih dermatologa s međunarodnim sudjelovanjem, 58-58, 2022 | | 2022 |
